Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
YkjXF5Hh76rgE7Hc
Listen
